← FDA DRUG APPROVALS

FDA ANDA · ANDA208804

ALBUTEROL

Sponsor: AMNEAL PHARMS CO

APPLICATION
ANDA208804
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-21
LATEST ACTION
2018-05-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 4MG BASE · TABLET · ORAL
ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 2MG BASE · TABLET · ORAL

Approval history

2018-05-21UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →